Latest in Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game changing pain treatment.
Sort by
2,934 items
-
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.CNBC - 44m -
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.The New York Times - 15h -
How DeepSeek Changed the A.I. Game
What is DeepSeek, and why did it cause the markets and U.S. tech giants to quake? Cade Metz, a technology reporter for The New York Times who writes about artificial intelligence, explains.The New York Times - 2d -
Black boxes found from crashed jet and FDA approves a new nonopioid painkiller: Morning Rundown
The D.C. plane crash renews concerns about air accidents in high-traffic areas.NBC News - 3h -
Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment.
Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment.MarketWatch - 6h -
‘Groundbreaking’ sickle cell disease treatment approved for NHS use in England
Clinical trials find one-time gene therapy exa-cel offers ‘functional cure’ in 96.6% of patients. A “groundbreaking” £1.65m treatment offering a potential cure for people in England living with ...The Guardian - 9h -
FDA approves new type of non-opioid pain medication
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...The Hill - 13h -
US regulators approve new non-opioid drug to treat acute pain
Oral drug from Vertex, branded as Journavx, represents alternative to addictive opioids that have fueled US crisis . The US Food and Drug Administration approved a new drug to treat acute pain, the ...The Guardian - 15h -
FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex Pharmaceuticals said.NBC News - 16h -
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.CNBC - 2d -
Starbucks Just Made a Huge Change That Will Make Customers Very Happy
Starbucks is trying to change not just how you think about its brand, but more importantly how you feel.Inc. - 3d -
Undergraduate certificate programs soar in popularity amid changes to labor market
The shifting labor market has fueled a huge spike in undergraduate certificate programs, which are vastly outpacing the growth in undergraduate enrollment in general. From 2019 to last fall, the ...The Hill - 3d -
2025 Super Bowl: Eagles' Brandon Graham speaks on potential return just two months after tearing his triceps
The longtime Eagles pass rusher hasn't played since Week 12CBS Sports - 4d -
Walmart Just Made a Big Announcement, and Its Best Employees Will Be Very Happy
The surprising pay for Walmart market managers: Are they worth more than half-a-million a year?Inc. - 5d -
This restaurant stock that tripled in 2024 just got downgraded ahead of earnings
The stock of Chili’s parent Brinker has rallied so much that a longtime bull downgraded it ahead of earnings, saying valuations leave “little room for error.”MarketWatch - 6d -
GE Aerospace looks to ‘compound’ investor returns. Stock soars to 18-year high.
GE Aerospace said that it plans to buy back $7 billion in stock and raise dividends by 30% this year.MarketWatch - Jan. 23 -
Three potential fantasy football draft trends we might just see in 2025
Andy Behrens offers a way-too-early look at plausible draft trends for next fantasy football season.Yahoo Sports - Jan. 23 -
Netflix keeps defying the doubters. One now thinks the stock could soar 56%.
How long can Netflix’s stock stay hot? With sports and advertising both cooking, one formerly neutral analyst now sees recent business momentum continuing for years.MarketWatch - Jan. 23 -
Patrick Mahomes on perception of Chiefs' preferential officiating treatment: Players decide games, not calls
K.C. hasn't been flagged for more penalties than an opponent in 11 straight playoff gamesCBS Sports - Jan. 22 -
Insomniac Games Teases Potential Return To The Movies Under Its New Leadership
Big changes are taking place at Marvel's Spider-Man developer Insomniac Games, and with new leaders stepping in to take over the studio, the team is once again interested in bringing some of its ...GameSpot - Jan. 22 -
Nose spray to treat depression? FDA approves first-of-its-kind medicine
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.The Hill - Jan. 22 -
FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment
Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.CNBC - Jan. 21 -
Forget the ‘Magnificent 7.’ These ‘MAGA 7’ stocks have soared since Trump’s election.
These are the stocks that have reacted the most to Donald Trump’s presidential election victory.MarketWatch - Jan. 21 -
Has South Korea just witnessed its own January 6 moment?
Protesters who stormed a Seoul court at the weekend may not have worn animal skins, but the similarities are striking. They arrived intent on causing mayhem. The political figurehead they supported ...The Guardian - Jan. 20 -
Trump launches surprise meme coin just before inauguration, and its price soars
President-elect Donald Trump launched his own meme coin early Saturday morning, creating excitement in the cryptocurrency world as the price and market capitalization of the coin immediately soared.MarketWatch - Jan. 20 -
The stock market’s ‘Trump bump’ will be back. Just be patient.
The stock market’s rough 2025 start should smooth out after the presidential inauguration.MarketWatch - Jan. 18 -
Trump is unpopular with many Americans. The stock market approves.
Trump’s current approval rating — 47.2% — is in the sweet spot for above-average stock market gains.MarketWatch - Jan. 18 -
'It's just hooping': Despite obvious changes, Unrivaled stars are ready for new league
While there are significant differences from the 3x3 game we've seen in FIBA and Olympic play, many of the stars have some degree of familiarity with the format.Yahoo Sports - Jan. 16 -
Abbott sued over its marketing of potentially harmful toddler milk
Formulas marketed for toddlers are a burgeoning business, but pediatricians have long recommended against their use.CBS News - Jan. 15 -
Chronic Pain: Five Things We Know About Causes, Treatments and Diagnoses
After developing chronic pain, I started looking into what scientists do — and still don’t — understand about the disease. Here is what I learned.The New York Times - Jan. 12 -
Tired market timers are just what stocks need to rally again
Be worried when timers are stubbornly bullish after a big downturn.MarketWatch - Jan. 11 -
Constellation’s stock soared on AI hopes. Now the energy company is using those gains to buy Calpine in $16 billion deal.
Constellation Energy Corp., an electricity provider whose stock has doubled over the last year on hopes it will help meet the voracious energy demand created by artificial-intelligence ...MarketWatch - Jan. 10 -
Nvidia stocks soar after GeForce RTX 50 series debuts at CES
Chipmaker Nvidia shares surge after founder Jensen Huang unveils next generation of AI for gamers at CES 2025.CBS News - Jan. 7 -
Getty’s stock soars 42% after image company agrees to merge with Shutterstock in $3.7 billion deal
The deal is expected to generate annual cost synergies of $150 million to $200 million by year three and to boost earnings and cash flow by year two.MarketWatch - Jan. 7 -
Stock market manages strong start to 2025. But watch for these potential pitfalls.
Stock-market investors are just two days into the new year but managed to halt the slide that damped the end of a still stellar 2024.MarketWatch - Jan. 5 -
Is America Just Going to Abandon Its Towns Falling Into the Ocean?
Communities must be able to move to solid ground while remaining whole.The New York Times - Jan. 4 -
This factor makes 11 stocks look like better bargains even after they soared in 2024
Some stocks’ price-to-earnings valuations declined even as they outpaced the S&P 500’s big gain.MarketWatch - Jan. 4 -
Indian village that changed its name to honor Jimmy Carter pays tribute
A village in India named after the late former President Jimmy Carter fondly remembers his visit almost 50 years ago.NBC News - Jan. 3 -
